Five Things You Need to Know to Start Your Day

Asset managers have boosted their short bets on the U.S. dollar to record levels

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Lorcan Roche Kelly

December 1, 2020 at 11:42 AM UTC

More vaccine progress, Powell and Mnuchin testify, and OPEC+ talks delayed.

Pfizer Inc. and partner BioNTech SE sought regulatory clearance for their Covid-19 vaccine in Europe, following a similar move from Moderna Inc. yesterday. This puts the vaccines on track for approval before the end of the year. Vice President Mike Pence signaled a swift response from U.S. regulators, saying that distribution of a vaccine could begin as early as the third week in December. Separately, there is new evidence that Covid-19 was in the U.S. earlier than previously recognized with a study finding infections in blood samples collected in late 2019.